DCF — PLATTE VALLEY MEDICAL CENTER
Enterprise Value: $-345.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-345.4M
Enterprise Value
$-108.3M
PV of Cash Flows
$-237.2M
PV of Terminal Value
$-381.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $186.4M | $-22.1M | -12.0% | $-30.0M | $-27.2M |
| Year 2 | $192.0M | $-20.8M | -11.0% | $-28.9M | $-23.9M |
| Year 3 | $197.8M | $-19.5M | -10.0% | $-27.8M | $-20.9M |
| Year 4 | $203.7M | $-19.0M | -9.0% | $-27.6M | $-18.9M |
| Year 5 | $209.8M | $-19.1M | -9.0% | $-27.9M | $-17.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-345.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$181.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12337349132106659
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5